PRHI:NASDAQPresurance Holdings, Inc. analysis
Data as of Jun 5, 2026 - not real-time
- Latest price
- $5.70
- Risk: high
- 8/10High risk
Summary
Technical outlook shows modest bullishness – the price sits above the 20‑day and 50‑day SMAs, RSI is at 60, and MACD is bullish, with support around $4.13 and resistance near $6.40. However, the fundamentals are severely strained: revenue fell 38.5% YoY, gross margin is negative, net profit margin is –50%, and the company posted a trailing EPS of –9.8. Cash balances exceed debt, but operating and free cash flow are deeply negative, and ROE is –64%.
Recent material events add to the uncertainty: a 1‑for‑7 reverse stock split took effect on June 1, 2026, and the Q1 2026 results (announced May 13) continued to reflect the loss‑making trend. While the stock trades at a low price‑to‑book (0.85) and price‑to‑sales (0.65), the extreme 30‑day volatility (over 100%) and a historic max drawdown of 76% underscore a high‑risk profile.
Recent material events add to the uncertainty: a 1‑for‑7 reverse stock split took effect on June 1, 2026, and the Q1 2026 results (announced May 13) continued to reflect the loss‑making trend. While the stock trades at a low price‑to‑book (0.85) and price‑to‑sales (0.65), the extreme 30‑day volatility (over 100%) and a historic max drawdown of 76% underscore a high‑risk profile.
Market outlook
Short term
< 1 yearCautious
Model confidence7/107 out of 10
Key factors
- Reverse split creates price volatility and uncertainty
- Negative earnings and cash flow
- Very high short‑term price volatility
Medium term
1–3 yearsNeutral
Model confidence5/105 out of 10
Key factors
- Cheap valuation relative to book and sales
- Potential for operational turnaround if losses are curbed
- Continued cash burn and debt load remain concerns
Long term
> 3 yearsCautious
Model confidence6/106 out of 10
Key factors
- Sustained negative profitability and ROE
- High debt‑to‑equity ratio for a small‑cap insurer
- Sector competitive pressures and regulatory headwinds
Key metrics
Financial health
Revenue Growth-38.50%
Profit Margin-50.02%
ROE-64.36%
ROA-4.36%
Debt/Equity80.39
P/B Ratio0.8
Op. Cash Flow$-36931000
Free Cash Flow$-20461750
Industry P/E17.0
Technical analysis
TrendNeutral
RSI60.5
Support$4.13
Resistance$6.40
MA 20$4.93
MA 50$4.83
MA 200$6.28
MACDBullish
VolumeIncreasing
Fear & Greed Index92.95
Valuation
GradeUndervalued
TypeValue
Risk assessment
Beta0.90
Volatility103.16%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.